PTC THERAPEUTICS, INC. — Director's Dealing 2019

Mar 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-03-05

Reporting Person: Utter Christine Marie (Principal Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-05	Common Stock	S	1509	$34.78	Disposed	5937	Direct
2019-03-05	Common Stock	S	1000	$35.25	Disposed	4937	Direct
2019-03-05	Common Stock	M	1150	$10.85	Acquired	6087	Direct
2019-03-05	Common Stock	S	540	$34.71	Disposed	5547	Direct
2019-03-05	Common Stock	S	610	$35.17	Disposed	4937	Direct
2019-03-05	Common Stock	M	18750	$13.10	Acquired	23687	Direct
2019-03-05	Common Stock	S	9929	$34.75	Disposed	13758	Direct
2019-03-05	Common Stock	S	8821	$35.21	Disposed	4937	Direct
2019-03-05	Common Stock	M	6300	$11.23	Acquired	11237	Direct
2019-03-05	Common Stock	S	2760	$34.70	Disposed	8477	Direct
2019-03-05	Common Stock	S	3540	$35.17	Disposed	4937	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-05	Stock Option (Right To Buy)	$10.85	M	1150	Disposed	2023-05-15	Common Stock (1150.0)	Direct
2019-03-05	Stock Option (Right To Buy)	$13.1	M	18750	Disposed	2027-06-02	Common Stock (18750.0)	Direct
2019-03-05	Stock Option (Right To Buy)	$11.23	M	6300	Disposed	2027-01-02	Common Stock (6300.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (74.0)	74	Direct
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (21.0)	21	Direct
Stock Option (Right To Buy)	$27.05	2024-01-28	Common Stock (3369.0)	3369	Direct
Stock Option (Right To Buy)	$40.45	2024-09-23	Common Stock (4688.0)	4688	Direct
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (17800.0)	17800	Direct
Stock Option (Right To Buy)	$30.86	2026-01-03	Common Stock (11000.0)	11000	Direct
Stock Option (Right To Buy)	$18.01	2028-01-02	Common Stock (40000.0)	40000	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (42500.0)	42500	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (10100.0)	10100	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.29 to $34.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.00 to $35.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.29 to $34.94 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.96 to $35.40 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.06 to $34.99 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F7: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.00 to $35.71 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F8: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.96 to $35.44 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F9: Currently exercisable.

F10: This option was granted on June 2, 2017, and vests over two years, with 50% of the shares underlying the option vesting on June 2, 2018, and an additional 12.5% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 2, 2018.

F11: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.

F12: This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.

F13: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.

F14: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F15: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.